Image: news-medical.net · rights & removal

Could the gut be priming the body for a more severe stroke?

Reporting by News-Medical.NetRead the original at news-medical.net

Executive Summary

Gut microbiota composition may influence ischemic stroke severity by modulating immune responses through the aryl hydrocarbon receptor (AHR) signaling pathway in intestinal dendritic cells. Research using a transient middle cerebral artery occlusion model explored how microbial profiles correlate with stroke outcomes, revealing that severe stroke was associated with changes in ileal microbial diversity, including depletion of certain obligate anaerobes and enrichment of *E. coli*. Fecal microbiota transplantation experiments investigated whether microbial factors from stroke patients influence immune responses via indole metabolites measured in various samples. Administration of indole in mice increased infarct volume and neurological deficits, and this effect correlated with AHR-based responses in dendritic cells. Depleting regulatory T cells (Tregs) reversed the neuroprotective effects observed following AHR inhibition in mice, suggesting Tregs are necessary for protection. Human metagenomic analyses showed enrichment of *E. coli* and *tnaA* in stroke patients, but associations were complex upon adjustment for clinical factors.

Facts Only

* Gut microbes modulate immune function and the risk of neurological disorders.
* Intestinal microbes may influence ischemic stroke severity through aryl hydrocarbon receptor (AHR) signaling that regulates dendritic cell (DC) function.
* Metagenomic investigations evaluated microbial profiles associated with stroke severity in mice using a transient middle cerebral artery occlusion (tMCAO) model.
* Fecal microbiota transplantation experiments involved transplanting samples from individuals with varying neurological deficit severities into mice.
* Indole levels were measured in ileum, plasma, stool, and urine samples using Kovács assays and mass spectrometry.
* Administration of indole increased infarct volume and neurological deficits in mice.
* AHR blockade increased C-C chemokine receptor type 7 (CCR7)-based migratory activity in intestinal DCs.
* Experimental depletion of Tregs abolished the early neuroprotective effect of AHR inhibition in mice.
* The study observed transient reductions in *Cyp1a1* and *Ahrr* genes 16 hours post-stroke, followed by increases in *Cyp1b1* in the ileum at 72 hours.

Full Take

The research establishes a complex communication network between the gut microbiome, AHR signaling, intestinal immune cells, and neurological injury severity. The pattern suggests that microbial composition programs intestinal immune responses which subsequently influence systemic inflammation and potential neuroprotection following stroke. The core implication is that gut-brain axis dysfunction may be mediated by microbial metabolic byproducts, such as indole, acting through receptors like AHR to modulate dendritic cell function and T-cell populations (Tregs). The observed necessity of Tregs for the protective effects induced by AHR inhibition suggests a crucial role for regulatory mechanisms in resolving post-stroke inflammation. However, the transition from murine models to human data remains correlative regarding direct causality between microbial tryptophan metabolism and stroke severity. Future research must focus on isolating the causal pathway: determining if microbiome-driven AHR signaling directly programs the immune landscape before physical brain injury occurs, and whether specific microbial metabolites serve as clinically relevant biomarkers or targets for intervention in human stroke susceptibility.

From the original · News-Medical.Net

A bacterial byproduct produced in the gut may alter immune cells before a stroke occurs, offering new clues about why brain injury can vary so widely in severity. Study: Gut microbiota primes stroke severity via the AHR in intestinal dendritic cells.

Read the full story at news-medical.net

Sentinel — provisional

Raw score, 0 to 1 (uncalibrated)0.45

No strong signs of machine writing were found in the source article. Provisional estimate, not a finding that a person wrote it.

The model's own note (unverified)

The text reads like a distillation or summary of complex biomedical research, characterized by precise terminology and nuanced discussion of limitations.

This looks only at the wording of the original source article, not at this page's AI-written sections. A small local AI model made this estimate. It has not been checked against known human and machine texts, so treat it as provisional. It cannot show who wrote an article.

What the model noticed in the source article

Moderate sentence length variance and domain-specific vocabulary; uses formal scientific phrasing.

Maintains a logical flow tracing the experimental setup, results, mechanistic steps, and limitations without overly synthetic hedging.

Follows a typical scientific narrative structure (Hypothesis -> Methods -> Results -> Discussion), with specific data points cited.

References highly specific experimental techniques (FMT, WGS, scRNA-seq, Kovács assays) and named molecules/cell types, which suggests grounding in actual research synthesis rather than pure generation.

Signs the model read as against machine writing

Specific citation of experimental models (tMCAO), specific markers (AHR, Treg, CCR7), and the inclusion of explicit methodological caveats ('correlation, rather than a causal relationship in humans', 'not establish a comparable anti-inflammatory cytokine response').